I received an email from one of our readers yesterday in response to the Breast Implant Redux post telling me about the FDA Scientific Fairness to Women Act, which Rep. Rosa L. DeLauro (D-CT) re-introduced to Congress yesterday. The purpose of the bill is to make women’s health issues a priority at the Food and Drug Administration (FDA) and among other things, it would:
§ Elevate the Office of Women's Health within the FDA so that the office reports directly to the Commissioner, instead of being buried two levels down from the Commissioner;
§ Rescind approval of silicone breast implants if the manufacturers cannot conclusively demonstrate their safety for the life of the implant; and
§ Require to FDA to convene a workshop to review and evaluate current scientific data on the use of emergency contraception by young women under the age of 18.
Needless to say, I’m guessing this very important impending bill is hardly likely to appear in the mainstream media. But women need to know about this important legislation -- You can contact your representative here to support the bill. Feel free to pass this information on.
Friday, May 25, 2007
FDA Scientific Fairness to Women Act
Posted by
Linda MacDonald Glenn
I'm reading: FDA Scientific Fairness to Women ActTweet this!
at
9:11 AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment